Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
Publications
Publications
  • April 2009 (Revised April 2009)
  • Case
  • HBS Case Collection

Immusol and Novartis

By: Regina E. Herzlinger, Keyne M. Monson, Juan D. Betancourt and Victor Li
  • Format:Print
  • | Pages:29
ShareBar

Abstract

Should Immusol strive to become a fully integrated pharmaceutical company? How should a small pharmaceutical company structure a deal for its novel technology with the giant Novartis?

Keywords

Technological Innovation; Rights; Negotiation Deal; Negotiation Participants; Alliances; Pharmaceutical Industry

Citation

Herzlinger, Regina E., Keyne M. Monson, and Juan D. Betancourt. "Immusol and Novartis." Harvard Business School Case 303-038, April 2009. (Revised from original October 2002 version.)
  • Educators
  • Purchase

About The Author

Regina E. Herzlinger

General Management
→More Publications

Related Work

    • April 2009 (Revised April 2009)
    • Faculty Research

    Immusol and Novartis

    By: Regina E. Herzlinger, Keyne M. Monson, Juan D. Betancourt and Victor Li
Related Work
  • Immusol and Novartis By: Regina E. Herzlinger, Keyne M. Monson, Juan D. Betancourt and Victor Li
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College